Role of Whole Plant Extract of Nelumbo nucifera Gaertn in the Treatment of Thrombolysis

Author(s): Charu Sharma, Samrat Chauhan, Sumeet Gupta*, Ashwanti Devi, Anroop Nair.

Journal Name: Cardiovascular & Hematological Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents)

Volume 17 , Issue 2 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Aim: This study aims to find out the components responsible for the antithrombotic activity of Nelumbo nucifera.

Material and Methods: Petroleum ether, chloroform and hydroalcoholic extracts of whole plant of Nelumbo nucifera (Lotus) were prepared and assessed for its thrombolytic, anti-platelet aggregation activity and bleeding time. The extracts were further analyzed through HPTLC and GC-MS. Statistical analysis was conducted through ANOVA trailed by Tukey’s multiple comparison test test.

Results: Hydroalcoholic extract showed the highest activity at the concentration of 400µg/ml in thrombolytic assay (42.03 ± 5.76), anti-platelet aggregation assay (57.93 ± 1.68) and bleeding time (70.17 ± 2.16) in comparison to clopodigrel (33.76 ± 3.43), aspirin (66.55 ± 1.86) and aspirin (93.85 ± 2.75) at the concentration of 100 µg/ml respectively. 25 peaks were identified through GC-MS, out of which, ferulic acid (14.2µ/g) and quercetin (5.4 µ/g) are active chemical compounds. HPTLC showed different chromatograms in hydroalcoholic extracts like (1) chlorogenic, (2) quercetin, (3) benzoic acid, (4) caffeic acid, (5) ferulic acid, (6) kaempferol, and (7) gallic acid.

Conclusion: Based on these findings, flavonoids present in hydroalcoholic extract may be developed into a drug for clinical application for the treatment of thrombosis in patients.

Keywords: Bioactive extracts, cardiovascular blood disorders, lotus plant, platelet aggregation assay, qualitative analysis, thrombolysis.

[1]
Almeida Chaves, D.S.; DeMelo, G.O.; Corrêa, M.F.P. A review of recent patents regarding antithrombotic drugs derived from natural products. Nat. Pro. Chem., 2018, 61, 1-47.
[2]
Fares, A. Winter cardiovascular diseases phenomenon. N. Am. J. Med. Sci., 2013, 5(4), 266-279.
[http://dx.doi.org/10.4103/1947-2714.110430] [PMID: 23724401]
[3]
Weitz, J.I.; Hirsh, J.; Samama, M.M. New anticoagulant drugs: The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest, 2004, 126(3)(Suppl.), 265S-286S.
[http://dx.doi.org/10.1378/chest.126.3_suppl.265S] [PMID: 15383475]
[4]
Beckman, M.G.; Hooper, W.C.; Critchley, S.E.; Ortel, T.L. Venous thromboembolism: A public health concern. Am. J. Prev. Med., 2010, 38(4)(Suppl.), S495-S501.
[http://dx.doi.org/10.1016/j.amepre.2009.12.017] [PMID: 20331949]
[5]
Li, S.; Ji, H.; Cheng, X.; Li, B.X.Y.; Ng, T.B. Antithrombotic and thrombolytic activities of Agkisacutacin, a snake venom proteinase, in experimental models. Gen. Pharmacol., 2000, 35(4), 179-187.
[http://dx.doi.org/10.1016/S0306-3623(01)00097-0] [PMID: 11827724]
[6]
Han, N.; Gu, Y.; Ye, C.; Cao, Y.; Liu, Z.; Yin, J. Antithrombotic activity of fractions and components obtained from raspberry leaves (Rubus chingii). Food Chem., 2012, 132(1), 181-185.
[http://dx.doi.org/10.1016/j.foodchem.2011.10.051] [PMID: 26434278]
[7]
Li, C.; Zhang, X.; Zhao, M.; Wang, Y.; Wu, J.; Liu, J.; Zheng, M.; Peng, S. A class of novel N-(1-methyl-β-carboline-3-carbonyl)-N′-(aminoacid-acyl)-hydrazines: aromatization leaded design, synthesis, in vitro anti-platelet aggregation/in vivo anti-thrombotic evaluation and 3D QSAR analysis. Eur. J. Med. Chem., 2011, 46(11), 5598-5608.
[http://dx.doi.org/10.1016/j.ejmech.2011.09.027] [PMID: 21983333]
[8]
Arslan, R.; Bor, Z.; Bektas, N.; Meriçli, A.H.; Ozturk, Y. Antithrombotic effects of ethanol extract of Crataegus orientalis in the carrageenan-induced mice tail thrombosis model. Thromb. Res., 2011, 127(3), 210-213.
[http://dx.doi.org/10.1016/j.thromres.2010.11.028] [PMID: 21183208]
[9]
Sa, Y.S.; Kim, S.J.; Choi, H.S. The anticoagulant fraction from the leaves of Diospyros Kaki L has an antithrombotic activity. Arch. Pharm. Res., 2011, 32, 48-51.
[PMID: 16042075]
[10]
Pan, J.; Qian, Y.; Zhou, X.; Pazandak, A.; Frazier, S.B.; Weiser, P.; Lu, H.; Zhang, L. Oversulfated chondroitin sulfate is not the sole contaminant in heparin. Nat. Biotechnol., 2010, 28(3), 203-207.
[http://dx.doi.org/10.1038/nbt0310-203] [PMID: 20212477]
[11]
Baker, W.L.; Johnson, S.G. Pharmacogenetics and oral antithrombotic drugs. Curr. Opin. Pharmacol., 2016, 27, 38-42.
[http://dx.doi.org/10.1016/j.coph.2016.01.008] [PMID: 26878737]
[12]
Stone, W.M.; Tonnessen, B.H.; Money, S.R. The new anticoagulants. Perspect. Vasc. Surg. Endovasc. Ther., 2007, 19(3), 332-335.
[http://dx.doi.org/10.1177/1531003507304441] [PMID: 17911567]
[13]
Bounameaux, H. The novel anticoagulants: entering A new era. Swiss Med. Wkly., 2009, 139(5-6), 60-64.
[PMID: 19204837]
[14]
Duke, J.A. Handbook of Medicinal Herbs, 2nd ed; CRC Press, 2002, p. 473.
[http://dx.doi.org/10.1201/9781420040463]
[15]
Tungmunnithum, D.; Pinthong, D.; Hano, C. Flavonoids from Nelumbo nucifera Gaertn., a medicinal plant: Uses in traditional medicine, phytochemistry and pharmacological activities. Medicines (Basel), 2018, 5(4), 127.
[http://dx.doi.org/10.3390/medicines5040127] [PMID: 30477094]
[16]
Khare, C.P. Indian Herbal Remedies: Rational Western Therapy, Ayurvedic, and Other Traditional Usage, Botany.Springer; 1st edn; USA. , 2004, pp. 326-327.
[17]
Sridhar, K.R.; Bhat, R. Lotus: A potential nutraceutical source. Agric. Technol. Thail., 2007, 3, 143-155.
[18]
Kim, J.H.; Kang, M.; Cho, C.; Chung, H.S.; Kang, C.W.; Parvez, S.; Bae, H. Effects of Nelumbinis Semen on contractile dysfunction in ischemic and reperfused rat heart. Arch. Pharm. Res., 2006, 29(9), 777-785.
[http://dx.doi.org/10.1007/BF02974079] [PMID: 17024852]
[19]
Ono, Y.; Hattori, E.; Fukaya, Y.; Imai, S.; Ohizumi, Y. Anti-obesity effect of Nelumbo nucifera leaves extract in mice and rats. J. Ethnopharmacol., 2006, 106(2), 238-244.
[http://dx.doi.org/10.1016/j.jep.2005.12.036] [PMID: 16495025]
[20]
Ohkoshi, E.; Miyazaki, H.; Shindo, K.; Watanabe, H.; Yoshida, A.; Yajima, H. Constituents from the leaves of Nelumbo nucifera stimulate lipolysis in the white adipose tissue of mice. Planta Med., 2007, 73(12), 1255-1259.
[http://dx.doi.org/10.1055/s-2007-990223] [PMID: 17893829]
[21]
Onishi, E.; Yamada, K.; Yamada, T.; Kaji, K.; Inoue, H.; Seyama, Y.; Yamashita, S. Comparative effects of crude drugs on serum lipids. Chem. Pharm. Bull. (Tokyo), 1984, 32(2), 646-650.
[http://dx.doi.org/10.1248/cpb.32.646] [PMID: 6733810]
[22]
Prasad, S.; Kashyap, R.S.; Deopujari, J.Y.; Purohit, H.J.; Taori, G.M.; Daginawala, H.F. Development of an in vitro model to study clot lysis activity of thrombolytic drugs. Thromb. J., 2006, 4, 14.
[http://dx.doi.org/10.1186/1477-9560-4-14] [PMID: 16968529]
[23]
Dejana, E.; Callioni, A.; Quintana, A.; de Gaetano, G. Bleeding time in laboratory animals. II - A comparison of different assay conditions in rats. Thromb. Res., 1979, 15(1-2), 191-197.
[http://dx.doi.org/10.1016/0049-3848(79)90064-1] [PMID: 483275]
[24]
Kim, T.H.; Ku, S.K.; Bae, J.S. Antithrombotic and profibrinolytic activities of eckol and dieckol. J. Cell. Biochem., 2012, 113(9), 2877-2883.
[http://dx.doi.org/10.1002/jcb.24163] [PMID: 22511271]
[25]
Koleckar, V.; Kubikova, K.; Rehakova, Z.; Kuca, K.; Jun, D.; Jahodar, L.; Opletal, L. Condensed and hydrolysable tannins as antioxidants influencing the health. Mini Rev. Med. Chem., 2008, 8(5), 436-447.
[http://dx.doi.org/10.2174/138955708784223486] [PMID: 18473933]
[26]
Gross, M. Flavonoids and cardiovascular disease. Pharm. Biol., 2004, 21-35.
[http://dx.doi.org/10.3109/13880200490893483]
[27]
Ogawa, H.; Stokes, D.L.; Sasabe, H.; Toyoshima, C. Structure of the Ca2+ pump of sarcoplasmic reticulum: A view along the lipid bilayer at 9-A resolution. Biophys. J., 1998, 75(1), 41-52.
[http://dx.doi.org/10.1016/S0006-3495(98)77493-4] [PMID: 9649366]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 17
ISSUE: 2
Year: 2019
Page: [115 - 124]
Pages: 10
DOI: 10.2174/1871525717666191016110706

Article Metrics

PDF: 17
HTML: 4